Lung Cancer
Camrelizumab – NSCLC | HongKong DengYue Medicine
Vizimpro (Dacomitinib) – NSCLC | HongKong DengYue Medicine
Keytruda (Pembrolizumab) – NSCLC | HongKong DengYue Medicine
Opdivo (Nivolumab) – NSCLC | HongKong DengYue Medicine
Zykadia (Ceritinib) – NSCLC | HongKong DengYue Medicine
Fukewai (Anlotinib Hydrochloride) – NSCLC | HongKong DengYue Medicine
Lazertinib | Non-Small Cell Lung Cancer | HongKong DengYue Medicine
Zenocutuzumab-Zbco｜Non-Small Cell Lung Cancer｜HongKong DengYue Medicine
Ensartinib | Non-small Cell Lung Cancer | HongKong DengYue Medicine
Encorafenib｜Non-Small Cell Lung Cancer｜HongKong DengYue Medicine
Tarlatamab-Dlle｜Extensive-Stage Small Cell Lung Cancer
Rezivertinib Mesylate Capsules｜Non-Small Cell Lung Cancer (NSCLC)
Capmatinib｜Non-Small Cell Lung Cancer (NSCLC)
Selpercatinib｜Thyroid Cancer｜HongKong DengYue Medicine
Lorbrena (Lorlatinib) – Lymphoma Kinase | HongKong DengYue Medicine
Augtyro Repotrectinib Capsules | Lung Cancer | DengYue
